104 related articles for article (PubMed ID: 24192928)
1. Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization.
Bommeljé CC; Weeda VB; Huang G; Shah K; Bains S; Buss E; Shaha M; Gönen M; Ghossein R; Ramanathan SY; Singh B
Clin Cancer Res; 2014 Jan; 20(2):372-81. PubMed ID: 24192928
[TBL] [Abstract][Full Text] [Related]
2. Correction to: Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2‑Antisense RNA 1/microRNA‑93‑5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
Appl Biochem Biotechnol; 2023 Dec; 195(12):7898-7899. PubMed ID: 37052864
[No Abstract] [Full Text] [Related]
3. SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1).
Huang G; Stock C; Bommeljé CC; Weeda VB; Shah K; Bains S; Buss E; Shaha M; Rechler W; Ramanathan SY; Singh B
J Biol Chem; 2014 Dec; 289(50):34728-42. PubMed ID: 25349211
[TBL] [Abstract][Full Text] [Related]
4. Targeting neddylation E2s: a novel therapeutic strategy in cancer.
Zheng YC; Guo YJ; Wang B; Wang C; Mamun MAA; Gao Y; Liu HM
J Hematol Oncol; 2021 Apr; 14(1):57. PubMed ID: 33827629
[TBL] [Abstract][Full Text] [Related]
5. NEDD8-conjugating enzyme E2s: critical targets for cancer therapy.
Zhou L; Lin X; Zhu J; Zhang L; Chen S; Yang H; Jia L; Chen B
Cell Death Discov; 2023 Jan; 9(1):23. PubMed ID: 36690633
[TBL] [Abstract][Full Text] [Related]
6. UBE2M promotes cell proliferation via the β-catenin/cyclin D1 signaling in hepatocellular carcinoma.
Zhang GC; Yu XN; Sun JL; Xiong J; Yang YJ; Jiang XM; Zhu JM
Aging (Albany NY); 2020 Feb; 12(3):2373-2392. PubMed ID: 32012120
[TBL] [Abstract][Full Text] [Related]
7. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
[TBL] [Abstract][Full Text] [Related]
8. Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.
Scott DC; Hammill JT; Min J; Rhee DY; Connelly M; Sviderskiy VO; Bhasin D; Chen Y; Ong SS; Chai SC; Goktug AN; Huang G; Monda JK; Low J; Kim HS; Paulo JA; Cannon JR; Shelat AA; Chen T; Kelsall IR; Alpi AF; Pagala V; Wang X; Peng J; Singh B; Harper JW; Schulman BA; Guy RK
Nat Chem Biol; 2017 Aug; 13(8):850-857. PubMed ID: 28581483
[TBL] [Abstract][Full Text] [Related]
9. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
[No Abstract] [Full Text] [Related]
10. SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.
Mathewson ND; Fujiwara H; Wu SR; Toubai T; Oravecz-Wilson K; Sun Y; Rossi C; Zajac C; Sun Y; Reddy P
Am J Pathol; 2016 Oct; 186(10):2679-91. PubMed ID: 27543965
[TBL] [Abstract][Full Text] [Related]
11. Prediction of neddylation sites from protein sequences and sequence-derived properties.
Yavuz AS; Sözer NB; Sezerman OU
BMC Bioinformatics; 2015; 16 Suppl 18(Suppl 18):S9. PubMed ID: 26679222
[TBL] [Abstract][Full Text] [Related]
12. Inactivating UBE2M impacts the DNA damage response and genome integrity involving multiple cullin ligases.
Cukras S; Morffy N; Ohn T; Kee Y
PLoS One; 2014; 9(7):e101844. PubMed ID: 25025768
[TBL] [Abstract][Full Text] [Related]
13. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
14. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway.
Lin Y; Li Y; Chen X; Jin X; Jiang M; Xiao H; Chen L; Chen M; Zhang W; Chen H; Nie Q; Guo R; Guo W; Fu F; Wang C
Biol Direct; 2024 Jun; 19(1):42. PubMed ID: 38831379
[TBL] [Abstract][Full Text] [Related]
15. A novel APA-based prognostic signature may predict the prognosis of lung adenocarcinoma in an East Asian population.
Zhang W; Hu Y; Qian M; Mao L; Yuan Y; Xu H; Liu Y; Qiu A; Zhou Y; Dong Y; Wu Y; Chen Q; Tao X; Tian T; Zhang L; Cui J; Chu M
iScience; 2023 Nov; 26(11):108068. PubMed ID: 37860689
[TBL] [Abstract][Full Text] [Related]
16. Targeting neddylation as a novel approach to lung cancer treatment (Review).
Tian Z; Li J; Ma R; Li T; Sun Z; Huang S
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37083098
[TBL] [Abstract][Full Text] [Related]
17. Identification of Ubiquitin-Related Gene-Pair Signatures for Predicting Tumor Microenvironment Infiltration and Drug Sensitivity of Lung Adenocarcinoma.
Li Y; An L; Jia Z; Li J; Zhou E; Wu F; Yin Z; Geng W; Liao T; Xiao W; Deng J; Chen W; Li M; Jin Y
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884544
[TBL] [Abstract][Full Text] [Related]
18. Identifying common transcriptome signatures of cancer by interpreting deep learning models.
Jha A; Quesnel-Vallières M; Wang D; Thomas-Tikhonenko A; Lynch KW; Barash Y
Genome Biol; 2022 May; 23(1):117. PubMed ID: 35581644
[TBL] [Abstract][Full Text] [Related]
19. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.
Nahalka J
Front Genet; 2021; 12():763995. PubMed ID: 34659373
[TBL] [Abstract][Full Text] [Related]
20. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells.
Oh J; Pradella D; Shao C; Li H; Choi N; Ha J; Ruggiero S; Fu XD; Zheng X; Ghigna C; Shen H
Cells; 2021 Apr; 10(4):. PubMed ID: 33918758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
